|
29 Companies |
|
28 Products |
|
28 Products |
|
27 Mechanisms of Action |
|
0 Trials |
|
447 News |
|
| «12345678910» |
- Clinical: Clinical Trial of Lupeol for Mild-moderate Acne (clinicaltrials.gov) - May 29, 2014
P=N/A, N=25, Completed, Sponsor: Seoul National University Hospital
- azelaic acid gel / Generic mfg.
New P4 trial: Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study (clinicaltrials.gov) - May 26, 2014
P4, N=20, Recruiting, Sponsor: Derm Research, PLLC
- ||||||| adapalene/benzoyl peroxide / Generic mfg.
Trial completion: Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris (clinicaltrials.gov) - May 25, 2014
P3, N=503, Completed, Sponsor: Galderma R&D
Active, not recruiting --> Completed
- dapsone / Generic mfg.
Trial primary completion date: Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel (clinicaltrials.gov) - May 15, 2014
P4, N=30, Active, not recruiting, Sponsor: Derm Research, PLLC
Active, not recruiting --> Completed Trial primary completion date: Apr 2014 --> Jul 2014
- dapsone / Generic mfg.
Enrollment closed: Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel (clinicaltrials.gov) - May 15, 2014
P4, N=30, Active, not recruiting, Sponsor: Derm Research, PLLC
Trial primary completion date: Apr 2014 --> Jul 2014 Recruiting --> Active, not recruiting
- PF-05175157 / Pfizer
Trial withdrawal: Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris (clinicaltrials.gov) - May 11, 2014
P2, N=0, Withdrawn, Sponsor: Pfizer
Recruiting --> Active, not recruiting Not yet recruiting --> Withdrawn
- PF-05175157 / Pfizer
Enrollment change: Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris (clinicaltrials.gov) - May 11, 2014
P2, N=0, Withdrawn, Sponsor: Pfizer
Not yet recruiting --> Withdrawn N=60 --> 0
- ||||||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
Trial completion: A Efficacy and Safety of Duac (clinicaltrials.gov) - May 7, 2014
P3, N=1018, Completed, Sponsor: GlaxoSmithKline
N=60 --> 0 Active, not recruiting --> Completed
- ||| omiganan (CLS001) / Maruho
Trial initiation date: Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris (clinicaltrials.gov) - Apr 13, 2014
P2, N=320, Recruiting, Sponsor: Cutanea Life Sciences, Inc.
Active, not recruiting --> Completed Initiation date: Mar 2014 --> Apr 2014
- |||| omiganan (CLS001) / Maruho
Enrollment open: Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris (clinicaltrials.gov) - Apr 13, 2014
P2, N=320, Recruiting, Sponsor: Cutanea Life Sciences, Inc.
Initiation date: Mar 2014 --> Apr 2014 Not yet recruiting --> Recruiting
- |||| Enrollment open: A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions (clinicaltrials.gov) - Apr 9, 2014
P4, N=90, Recruiting, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| PF-05175157 / Pfizer
New P2 trial: Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris (clinicaltrials.gov) - Mar 30, 2014
P2, N=60, Not yet recruiting, Sponsor: Pfizer
- |||| Enrollment open: Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris. (clinicaltrials.gov) - Mar 11, 2014
P2, N=234, Recruiting, Sponsor: Galderma R&D
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||||| adapalene/benzoyl peroxide / Generic mfg.
Enrollment open: Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris. (clinicaltrials.gov) - Mar 9, 2014
P3, N=412, Recruiting, Sponsor: Galderma R&D
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||| adapalene/benzoyl peroxide / Generic mfg.
Trial completion: Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo (clinicaltrials.gov) - Mar 7, 2014
P1, N=2008, Completed, Sponsor: Taro Pharmaceuticals USA
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||| gevokizumab (VPM087) / Novartis
Enrollment change: Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris (clinicaltrials.gov) - Mar 2, 2014
P2, N=127, Completed, Sponsor: XOMA (US) LLC
Active, not recruiting --> Completed N=171 --> 127
- |||| gevokizumab (VPM087) / Novartis
Trial completion: Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris (clinicaltrials.gov) - Mar 2, 2014
P2, N=127, Completed, Sponsor: XOMA (US) LLC
N=171 --> 127 Active, not recruiting --> Completed
- |||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
Enrollment open: Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris (clinicaltrials.gov) - Feb 26, 2014
P4, N=220, Recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| adapalene/benzoyl peroxide / Generic mfg.
New P3 trial: Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris. (clinicaltrials.gov) - Feb 25, 2014
P3, N=412, Recruiting, Sponsor: Galderma R&D
- ||||| New P2 trial: Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris. (clinicaltrials.gov) - Feb 25, 2014
P2, N=234, Recruiting, Sponsor: Galderma R&D
- | NN1213 / Novo Nordisk
Trial completion: Non-cutting Laser Therapy in the Treatment of Acne (clinicaltrials.gov) - Feb 22, 2014
P2, N=75, Completed, Sponsor: University of Michigan
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||| omiganan (CLS001) / Maruho
New P2 trial: Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris (clinicaltrials.gov) - Feb 17, 2014
P2, N=320, Recruiting, Sponsor: Cutanea Life Sciences, Inc.
- ||||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
Enrollment closed: A Efficacy and Safety of Duac (clinicaltrials.gov) - Feb 12, 2014
P3, N=1020, Active, not recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||||||| Trial completion: Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne (clinicaltrials.gov) - Feb 11, 2014
P3, N=496, Completed, Sponsor: Valeant Pharmaceuticals International, Inc.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
New P4 trial: Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris (clinicaltrials.gov) - Feb 6, 2014
P4, N=220, Recruiting, Sponsor: GlaxoSmithKline
- Enrollment open: Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone (clinicaltrials.gov) - Feb 5, 2014
P=N/A, N=100, Recruiting, Sponsor: University of California, Davis
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| adapalene/benzoyl peroxide / Generic mfg.
Enrollment closed: Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris (clinicaltrials.gov) - Feb 4, 2014
P3, N=493, Active, not recruiting, Sponsor: Galderma R&D
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||||| New P4 trial: A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions (clinicaltrials.gov) - Jan 30, 2014
P4, N=90, Recruiting, Sponsor: GlaxoSmithKline
- Trial completion: Fractional CO2 Treatment of Acne Scars in Asians (clinicaltrials.gov) - Jan 23, 2014
P4, N=12, Completed, Sponsor: Mahidol University
Recruiting --> Active, not recruiting Recruiting --> Completed
- Enrollment closed: Feasibility Study: Ulthera (clinicaltrials.gov) - Jan 12, 2014
P=N/A, N=30, Active, not recruiting, Sponsor: Ulthera, Inc
Recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Teleacne: Use of Mobile Teledermatology in the Care of Acne Patients (clinicaltrials.gov) - Jan 11, 2014
P=N/A, N=69, Completed, Sponsor: Medical University of Graz
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- |||| berdazimer sodium (SB204) / Sato Pharma, Novan
Trial completion: A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne (clinicaltrials.gov) - Jan 9, 2014
P2, N=153, Completed, Sponsor: Novan, Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- | berdazimer sodium (SB204) / Sato Pharma, Novan
Trial completion: A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel (clinicaltrials.gov) - Jan 9, 2014
P1, N=30, Completed, Sponsor: Novan, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| dapsone / Generic mfg.
New P4 trial: A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris (clinicaltrials.gov) - Jan 8, 2014
P4, N=65, Recruiting, Sponsor: Allergan
- || adapalene/benzoyl peroxide / Generic mfg.
Enrollment change: Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo (clinicaltrials.gov) - Dec 18, 2013
P1, N=2008, Completed, Sponsor: Taro Pharmaceuticals USA
Active, not recruiting --> Completed N=965 --> 2008
- |||||| dapsone / Generic mfg.
Enrollment open: A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris (clinicaltrials.gov) - Dec 18, 2013
P3, N=2180, Recruiting, Sponsor: Allergan
N=965 --> 2008 Not yet recruiting --> Recruiting
- |||||| dapsone / Generic mfg.
Enrollment open: Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris (clinicaltrials.gov) - Dec 18, 2013
P3, N=2180, Recruiting, Sponsor: Allergan
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
Trial completion: A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac (clinicaltrials.gov) - Dec 18, 2013
P1, N=650, Completed, Sponsor: Taro Pharmaceuticals USA
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| benzoyl peroxide/clindamycin / Generic mfg., clindamycin phosphate / Generic mfg.
Trial completion: Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya (clinicaltrials.gov) - Dec 18, 2013
P1, N=1215, Completed, Sponsor: Taro Pharmaceuticals USA
Recruiting --> Completed Recruiting --> Completed
- |||| Trial completion: Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients (clinicaltrials.gov) - Nov 30, 2013
P1/2, N=157, Completed, Sponsor: M. Arkin 1999 Ltd.
Recruiting --> Completed Recruiting --> Completed
- ||| New P1 trial: Study to Investigate the Irritation Potential of GSK1940029 Gel (clinicaltrials.gov) - Nov 13, 2013
P1, N=71, Recruiting, Sponsor: GlaxoSmithKline
- Enrollment open: Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029 (clinicaltrials.gov) - Nov 6, 2013
P1, N=48, Recruiting, Sponsor: GlaxoSmithKline
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment change: Obesity and Clinical Presentation of Hyperandrogenism (clinicaltrials.gov) - Nov 3, 2013
P=N/A, N=46, Completed, Sponsor: Taipei Medical University WanFang Hospital
Not yet recruiting --> Recruiting N=100 --> 46
- |||||||||| dapsone / Generic mfg.
New P3 trial: A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris (clinicaltrials.gov) - Oct 30, 2013
P3, N=2180, Recruiting, Sponsor: Allergan
- |||||||||| dapsone / Generic mfg.
New P3 trial: Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris (clinicaltrials.gov) - Oct 30, 2013
P3, N=2180, Recruiting, Sponsor: Allergan
- Trial completion: Comparison of the Efficacy of Fractional Er:YAG Laser for Acne Scar (clinicaltrials.gov) - Oct 8, 2013
P=N/A, N=27, Completed, Sponsor: Seoul National University Hospital
N=100 --> 46 Not yet recruiting --> Completed
- | New P1 trial: Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029 (clinicaltrials.gov) - Sep 8, 2013
P1, N=48, Recruiting, Sponsor: GlaxoSmithKline
- ||||| adapalene/benzoyl peroxide / Generic mfg.
Enrollment closed: A Long Term Study of GK530G in Subjects With Acne Vulgaris (clinicaltrials.gov) - Sep 3, 2013
P3, N=436, Active, not recruiting, Sponsor: Galderma R&D
Not yet recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Is Acne a Skin Disease Affecting the Brain Functions? Neurocognition in Patients With Acne Vulgaris (clinicaltrials.gov) - Aug 26, 2013
P=N/A, N=66, Completed, Sponsor: Bezmialem Vakif University
Recruiting --> Active, not recruiting Not yet recruiting --> Completed
- | clindamycin phosphate / Generic mfg.
New P1 trial: W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers (clinicaltrials.gov) - Aug 21, 2013
P1, N=37, Completed, Sponsor: Stiefel, a GSK Company